FDA Approves 200th Antiretroviral Drug Application

FDA: PEPFAR: FDA Approves 200th HIV/AIDS Therapy
Scott Gottlieb, commissioner of the U.S. Food and Drug Administration, discusses the approval of the 200th antiretroviral drug application as well as FDA’s work with PEPFAR to develop HIV therapies and provide access to HIV treatment (12/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.